Mesenchymal stem cells as all-round supporters in a normal and neoplastic microenvironment

Cell Communication and Signaling

Volumn 10, Issue , 2012, Pages

  Hass, Ralf ^a   Otte, Anna ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Mesenchymal stem cells; Microenvironment; Tumor cells

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; MICRORNA;

ANGIOGENESIS; APOPTOSIS; BIODIVERSITY; CANCER GROWTH; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL INTERACTION; CELL INVASION; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CELL RENEWAL; EXOSOME; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; MACROPHAGE; MESENCHYMAL STEM CELL; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TISSUE INJURY; TISSUE REPAIR; TUMOR MICROENVIRONMENT; TUMOR PROMOTION; WOUND HEALING;

EID: 84866482255     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/1478-811X-10-26     Document Type: Review

References (144)

1. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Friedenstein AJ, Gorskaja JF, Kulagina NN, Exp Hematol 1976 4 267 274 976387
2. Fat tissue: an underappreciated source of stem cells for biotechnology. Fraser JK, Wulur I, Alfonso Z, Hedrick MH, Trends Biotechnol 2006 24 150 154 10.1016/j.tibtech.2006.01.010 16488036
3. Study on culture and in vitro osteogenesis of blood-derived human mesenchymal stem cells. Cao C, Dong Y, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 2005 19 642 647 16130394
4. Adult cardiac stem cells are multipotent and support myocardial regeneration. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, Leri A, Kajstura J, Nadal-Ginard B, Anversa P, Cell 2003 114 763 776 10.1016/S0092-8674(03)00687-1 14505575 (Pubitemid 37186770)
5. Stem cells of the alveolar epithelium. Griffiths MJ, Bonnet D, Janes SM, Lancet 2005 366 249 260 10.1016/S0140-6736(05)66916-4 16023517 (Pubitemid 40981054)
6. Isolation of amniotic stem cell lines with potential for therapy. De Coppi P, Bartsch G, Siddiqui MM, Xu T, Santos CC, Perin L, Mostoslavsky G, Serre AC, Snyder EY, Yoo JJ, Furth ME, Soker S, Atala A, Nat Biotechnol 2007 25 100 106 10.1038/nbt1274 17206138 (Pubitemid 46087908)
7. Stem cell characteristics of amniotic epithelial cells. Miki T, Lehmann T, Cai H, Stolz DB, Strom SC, Stem Cells 2005 23 1549 1559 10.1634/stemcells. 2004-0357 16081662 (Pubitemid 41741004)
8. Differentiation of mesenchymal cells derived from human amniotic membranes into hepatocyte-like cells in vitro. Tamagawa T, Oi S, Ishiwata I, Ishikawa H, Nakamura Y, Hum Cell 2007 20 77 84 10.1111/j.1749-0774.2007.00032.x 17645727 (Pubitemid 47084050)
9. Alternative sources of adult stem cells: human amniotic membrane. Wolbank S, van Griensven M, Grillari-Voglauer R, Peterbauer-Scherb A, Adv Biochem Eng Biotechnol 2010 123 1 27 20237903
10. Isolation and characterization of mesenchymal cells from human fetal membranes. Soncini M, Vertua E, Gibelli L, Zorzi F, Denegri M, Albertini A, Wengler GS, Parolini O, J Tissue Eng Regen Med 2007 1 296 305 10.1002/term.40 18038420
11. Isolation and characterization of mesenchymal progenitor cells from chorionic villi of human placenta. Igura K, Zhang X, Takahashi K, Mitsuru A, Yamaguchi S, Takashi TA, Cytotherapy 2004 6 543 553 10.1080/14653240410005366-1 15770794 (Pubitemid 40028913)
12. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Anker PS I't, Scherjon SA, van der Keur Kleijburg C, de Groot-Swings GM, Claas FH, Fibbe WE, Kanhai HH, Stem Cells 2004 22 1338 1345 10.1634/stemcells.2004-0058 15579651 (Pubitemid 39636409)
13. Molecular trafficking mechanisms of multipotent mesenchymal stem cells derived from human bone marrow and placenta. Brooke G, Tong H, Levesque JP, Atkinso K, Stem Cells Dev 2008 17 929 940 10.1089/scd.2007.0156 18564033
14. Cord blood stem and progenitor cells. Broxmeyer HE, Srour E, Orschell C, Ingram DA, Cooper S, Plett PA, Mead LE, Yoder MC, Methods Enzymol 2006 419 439 473 17141066 (Pubitemid 44820377)
15. Mesenchymal stem cells in the Whartons jelly of the human umbilical cord. Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, Fu YS, Lai MC, Chen CC, Stem Cells 2004 22 1330 1337 10.1634/stemcells.2004-0013 15579650 (Pubitemid 39636408)
16. Growth and differentiation properties of mesenchymal stromal cell populations derived from whole human umbilical cord. Majore I, Moretti P, Stahl F, Hass R, Kasper C, Stem Cell Rev Rep 2011 7 17 31 10.1007/s12015-010-9165-y
17. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Baksh D, Yao R, Tuan RS, Stem Cells 2007 25 1384 1392 10.1634/stemcells.2006-0709 17332507 (Pubitemid 47106005)
18. Differentiation of Wharton's jelly primitive stromal cells into insulin-producing cells in comparison with bone marrow mesenchymal stem cells. Wu LF, Wang NN, Liu YS, Wei X, Tissue Eng Part A 2009 15 2865 2873 10.1089/ten.tea.2008.0579 19257811
19. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells. Chen MY, Lie PC, Li ZL, Wei X, Exp Hematol 2009 37 629 640 10.1016/j.exphem.2009.02.003 19375653
20. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X, Gong W, Han ZB, Xu ZS, Lu YX, Liu D, Chen ZZ, Han ZC, Haematologica 2006 91 1017 1026 16870554
21. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K, Stem Cells 2006 24 1294 1301 10.1634/stemcells.2005-0342 16410387 (Pubitemid 44464698)
22. Comparative analysis of mesenchymal stem cells from bone marrow, cartilage, and adipose tissue. Peng L, Jia Z, Yin X, Zhang X, Liu Y, Chen P, Ma K, Zhou C, Stem Cells Dev 2008 17 761 773 10.1089/scd.2007.0217 18393634
23. Cellular responses to reactive oxygen species-induced DNA damage and aging. Bertram C, Hass R, Biol Chem 2008 389 211 220 18208352 (Pubitemid 351329029)
24. Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells. Lavrentieva A, Majore I, Kasper C, Hass R, Cell Commun Signal 2010 8 18 10.1186/1478-811X-8-18 20637101
25. 17-Beta estradiol enhances osteogenic and adipogenic differentiation of human adipose-derived stromal cells. Hong L, Colpan A, Peptan IA, Daw J, George A, Evans CA, Tissue Eng 2007 13 1197 1203 10.1089/ten.2006.0317 17518737 (Pubitemid 46986720)
26. Umbilical Cord Wharton's Jelly: A New Potential Cell Source of Mesenchymal Stromal Cells for Bone Tissue Engineering. Hou T, Xu J, Wu X, Xie Z, Luo F, Zhang Z, Zeng L, Tissue Eng Part A 2009 15 2325 34 10.1089/ten.tea.2008. 0402 19231937
27. Effects of transforming growth factor beta1 and dexamethasone on the growth and chondrogenic differentiation of adipose-derived stromal cells. Awad HA, Halvorsen YD, Gimble JM, Guilak F, Tissue Eng 2003 9 1301 1312 10.1089/10763270360728215 14670117 (Pubitemid 37467678)
28. Retrodifferentiation-a mechanism for cellular regeneration? Hass R, Biol Chem 2009 390 409 416 19335196
29. Rejuvenation in distinct cell populations-What does it mean? Hass R, Exp Gerontol 2009 44 634 638 10.1016/j.exger.2009.07.006 19638307
30. Isolation and characterization of true mesenchymal stem cells derived from human term decidua capable of multilineage differentiation into all 3 embryonic layers. Macias MI, Grande J, Moreno A, Domínguez I, Bornstein R, Flores AI, Am J Obstet Gynecol 2010 203 495 e9-495.e23 20822767
31. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair current views. Phinney DG, Prockop DJ, Stem Cells 2007 25 2896 2902 10.1634/stemcells.2007-0637 17901396 (Pubitemid 350127874)
32. Identification of subpopulations in mesenchymal stem cell-like cultures from human umbilical cord. Majore I, Moretti P, Hass R, Kasper C, Cell Commun Signal 2009 7 6 10.1186/1478-811X-7-6 19302702
33. Endogenous beta-galactosidase activity in continuously nonproliferating cells. Yegorov YE, Akimov SS, Hass R, Zelenin AV, Prudovsky IA, Exp Cell Res 1998 243 207 211 10.1006/excr.1998.4169 9716464 (Pubitemid 28397649)
34. Minimal criteria for defining multipotent mesenchymal stromal cells. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E, The International Society for Cellular Therapy position statement. Cytotherapy 2006 8 315 317
35. Primary Mesenchymal Stem and Progenitor Cells from Bone Marrow Lack Expression of CD44 Protein. Qian H, Le Blanc K, Sigvardsson M, J Biol Chem 2012 287 25795 807 10.1074/jbc.M112.339622 22654106
36. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Yu Q, Stamenkovic I, Genes Dev 1999 13 35 48 10.1101/gad.13.1.35 9887098 (Pubitemid 29045114)
37. MMP-7 is involved in aging of primary human mammary epithelial cells (HMEC). Bertram C, Hass R, Exp Gerontol 2008 43 209 217 10.1016/j.exger.2007.11. 007 18207346
38. Cellular senescence of human mammary epithelial cells (HMEC) is associated with an altered MMP-7/HB-EGF signaling and increased formation of elastin-like structures. Bertram C, Hass R, Mech Aging Dev 2009 30 657 669
39. Extracellular signals in young and aging breast epithelial cells and possible connections to age-associated breast cancer development. Chaturvedi S, Hass R, Mech Aging Dev 2011 132 213 219 10.1016/j.mad.2011.04.002 21507328
40. LEF-1 regulates proliferation and MMP-7 transcription in breast cancer cells. Bucan V, Mandel K, Bertram C, Lazaridis A, Reimers K, Park-Simon TW, Vogt PM, Hass R, Genes to Cells 2012 17 559 567 10.1111/j.1365-2443.2012.01613.x 22686279
41. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Simmons PJ, Torok-Storb B, Blood 1991 78 55 62 2070060
42. Selected Stro-1-enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferation. Nasef A, Zhang YZ, Mazurier C, Bouchet S, Bensidhoum M, Francois S, Gorin NC, Lopez M, Thierry D, Fouillard L, Chapel A, Int J Lab Hematol 2009 31 9 19 10.1111/j.1751-553X.2007.00997.x 19143868
43. Tissue distribution of mesenchymal stem cell marker Stro-1. Lin G, Liu G, Banie L, Wang G, Ning H, Lue TF, Lin CS, Stem Cells Dev 2011 20 1747 1752 10.1089/scd.2010.0564 21208041
44. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Honczarenko M, Le Y, Swierkowski M, Ghiran I, Glodek AM, Silberstein LE, Stem Cells 2006 24 1030 1041 10.1634/stemcells.2005- 0319 16253981 (Pubitemid 44464736)
45. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Méndez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, Lira SA, Scadden DT, Ma'ayan A, Enikolopov GN, Frenette PS, Nature 2010 466 829 834 10.1038/nature09262 20703299
46. Mesenchymal stem cells and neural crest stem cells from adult bone marrow: characterization of their surprising similarities and differences. Wislet-Gendebien S, Laudet E, Neirinckx V, Alix P, Leprince P, Glejzer A, Poulet C, Hennuy B, Sommer L, Shakhova O, Rogister B, Cell Mol Life Sci 2012 69 2593 2608 10.1007/s00018-012-0937-1 22349262
47. Interaction of tumor cells with the microenvironment. Ungefroren H, Sebens S, Seidl D, Lehnert H, Hass R, Cell Commun Signal 2011 9 18 10.1186/1478-811X-9-18 21914164
48. Cancer invasion and the microenvironment: plasticity and reciprocity. Friedl P, Alexander S, Cell 2011 147 992 1009 10.1016/j.cell.2011.11.016 22118458
49. Cancer invasion and resistance: interconnected processes of disease progression and therapy failure. Alexander S, Friedl P, Trends Mol Med 2012 18 13 26 10.1016/j.molmed.2011.11.003 22177734
50. Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Chen TS, Lai RC, Lee MM, Choo AB, Lee CN, Lim SK, Nucleic Acids Res 2010 38 215 224 10.1093/nar/gkp857 19850715
51. MicroRNAs and mesenchymal stem cells. Collino F, Bruno S, Deregibus MC, Tetta C, Camussi G, Vitam Horm 2011 87 291 320 22127248
52. The role of microRNAs in self-renewal and differentiation of mesenchymal stem cells. Guo L, Zhao RC, Wu Y, Exp Hematol 2011 39 608 616 10.1016/j.exphem.2011.01.011 21288479
53. Adipogenic differentiation of human mesenchymal stromal cells is down-regulated by microRNA-369-5p and up-regulated by microRNA-371. Bork S, Horn P, Castoldi M, Hellwig I, Ho AD, Wagner W, J Cell Physiol 2011 226 2226 2234 10.1002/jcp.22557 21660946
54. Chemokines in hematopoiesis. Broxmeyer HE, Current opinion in hematology 2008 15 49 58 10.1097/MOH.0b013e3282f29012 18043246 (Pubitemid 350191028)
55. MiR-886-3p down regulates CXCL12 (SDF1) expression in human marrow stromal cells. Pillai MM, Yang X, Balakrishnan I, Bemis L, Torok-Storb B, PLoS One 2010 5 12 14304 10.1371/journal.pone.0014304 21179442
56. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. Chen L, Tredget EE, Wu PY, Wu Y, PLoS ONE 2008 3 1886 10.1371/journal.pone.0001886 18382669 (Pubitemid 351943822)
57. Multipotent mesenchymal stromal cells and the innate immune system. Le Blanc K, Mougiakakos D, Nat Rev Immunol 2012 12 383 96 10.1038/nri3209 22531326
58. Macrophage-associated mesenchymal stem cells assume an activated, migratory, pro-inflammatory phenotype with increased IL-6 and CXCL10 secretion. Anton K, Banerjee D, Glod J, PLoS One 2012 7 35036 10.1371/journal.pone.0035036 22496888
59. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Spaggiari GM, Capobianco A, Abdelrazik H, Becchetti F, Mingari MC, Moretta L, Blood 2008 111 1327 1333 17951526 (Pubitemid 351213419)
60. Exploring the full spectrum of macrophage activation. Mosser DM, Edwards JP, Nature Rev Immunol 2008 8 958 969 10.1038/nri2448
61. Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. Maggini J, Mirkin G, Bognanni I, Holmberg J, Piazzán IM, Nepomnaschy I, Costa H, Cãones C, Raiden S, Vermeulen M, Geffner JR, PLoS ONE 2010 5 9252 10.1371/journal.pone.0009252 20169081
62. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. Sasaki M, Abe R, Fujita Y, Ando S, Inokuma D, Shimizu H, J Immunol 2008 180 2581 2587 18250469
63. Mesenchymal stem cells from adipose and bone marrow promote angiogenesis via distinct cytokine and protease expression mechanisms. Kachgal S, Putnam AJ, Angiogenesis 2011 14 47 59 10.1007/s10456-010-9194-9 21104120
64. Mesenchymal cells stimulate capillary morphogenesis via distinct proteolytic mechanisms. Ghajar CM, Kachgal S, Kniazeva E, Mori H, Costes SV, George SC, Putnam AJ, Exp Cell Res 2010 316 813 825 10.1016/j.yexcr.2010.01.013 20067788
65. Epithelial stem cells, wound healing and cancer. Arwert EN, Hoste E, Watt FM, Nat Rev Cancer 2012 12 170 180 10.1038/nrc3217 22362215
66. Immunosuppressive properties of mesenchymal stem cells: advances and applications. De Miguel MP, Fuentes-Julian S, Blazquez-Martinez A, Pascual CY, Aller MA, Arias J, Arnalich-Montiel F, Curr Mol Med 2012 12 574 591 22515979
67. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSC, whereas MSC can inhibit IL-2-induced NK-cell proliferation. Spaggiari GM, Capobianco A, Becchetti S, Mingari MC, Moretta L, Blood 2006 107 14841490
68. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Shiroishi M, Tsumoto K, Amano K, Shirakihara Y, Colonna M, Braud VM, Allan DS, Makadzange A, Rowland-Jones S, Willcox B, Jones EY, van der Merwe PA, Kumagai I, Maenaka K, Proceedings of the National Academy of Sciences of the United States of America 2003 100 8856 8861 10.1073/pnas.1431057100 12853576 (Pubitemid 36899188)
69. ILT2/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse. Favier B, Lemaoult J, Lesport E, Carosella ED, The FASEB journal: official publication of the Federation of American Societies for Experimental Biology 2010 24 689 699 10.1096/fj.09-135194
70. Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells. Gieseke F, Böhringer J, Bussolari R, Dominici M, Handgretinger R, Müller I, Blood 2010 116 3770 3779 10.1182/blood-2010-02- 270777 20644118
71. Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. Ren G, Zhao X, Zhang L, Zhang J, L'Huillier A, Ling W, Roberts AI, Le AD, Shi S, Shao C, Shi Y, J Immunol 2010 184 2321 2328 10.4049/jimmunol.0902023 20130212
72. Human mesenchymal stromal cells from adult and neonatal sources: comparative analysis of their morphology, immunophenotype, differentiation patterns and neural protein expression. Montesinos JJ, Flores-Figueroa E, Castillo-Medina S, Flores-Guzman P, Hernandez-Estevez E, Fajardo-Orduna G, Orozco S, Mayani H, Cytotherapy 2009 11 163 176 10.1080/14653240802582075 19152152
73. The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord blood. Zeddou M, Briquet A, Relic B, Josse C, Malaise MG, Gothot A, Lechanteur C, Beguin Y, Cell biology international 2010 34 693 701 10.1042/CBI20090414 20187873
74. Optimization of Culture Conditions for the Expansion of Umbilical Cord-Derived Mesenchymal Stem or Stromal Cell-Like Cells Using Xeno-Free Culture Conditions. Hatlapatka T, Moretti P, Lavrentieva A, Hass R, Marquardt N, Jacobs R, Kasper C, Tissue Eng Part C Methods 2011 4 485 493
75. Mesenchymal stromal cells derived from human umbilical cord tissues: primitive cells with potential for clinical and tissue engineering applications. Moretti P, Hatlapatka T, Marten D, Lavrentieva A, Majore I, Hass R, Kasper C, Advances in Biochemical Engineering/Biotechnology 2010 123 29 54 20012739
76. Immunomodulatory effects of mesenchymal stromal cells in solid organ transplantation. Casiraghi F, Noris M, Remuzzi G, Current opinion in organ transplantation 2010 15 731 737 10.1097/MOT.0b013e328340172c
77. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha. Haynesworth SE, Baber MA, Caplan AI, Journal of cellular physiology 1996 166 585 592 10.1002/(SICI)1097- 4652(199603)166:3<585::AID-JCP13>3.0.CO;2-6 8600162 (Pubitemid 26095485)
78. Tumor cell invasion inhibited by TIMP-2. Albini A, Melchiori A, Santi L, Liotta LA, Brown PD, Stetler-Stevenson WG, Journal of the National Cancer Institute 1991 83 775 779 10.1093/jnci/83.11.775 1645772
79. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, Grisanti S, Gianni AM, Blood 2002 99 3838 3843 10.1182/blood.V99.10.3838 11986244 (Pubitemid 34534559)
80. Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta. Patel SA, Meyer JR, Greco SJ, Corcoran KE, Bryan M, Rameshwar P, Journal of immunology (Baltimore, Md: 19 2010 184 5885 10.4049/jimmunol.0903143
81. Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts. Lama VN, Smith L, Badri L, Flint A, Andrei AC, Murray S, Wang Z, Liao H, Toews GB, Krebsbach PH, et al. The Journal of clinical investigation 2007 117 989 996 10.1172/JCI29713 17347686 (Pubitemid 46556755)
82. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts AI, Zhao RC, Shi Y, Cell stem cell 2008 2 141 150 10.1016/j.stem.2007. 11.014 18371435 (Pubitemid 351181031)
83. Rat mesenchymal stromal cells inhibit T cell proliferation but not cytokine production through inducible nitric oxide synthase. Zinöcker S, Vaage JT, Front Immunol 2012 3 62 22566943
84. Glucocorticoid-induced reduction of prostanoid synthesis in TPA-differentiated U937 cells is mainly due to a reduced cyclooxygenase activity. Koehler L, Hass R, DeWitt DL, Resch K, Goppelt-Struebe M, Biochem Pharmacol 1990 40 1307 1316 10.1016/0006-2952(90)90397-4 2119586 (Pubitemid 20311942)
85. Differential effect of dexamethasone on the regulation of phospholipase A2 and prostanoid synthesis in undifferentiated and phorbolester-differentiated U937 cells. Koehler L, Hass R, Goppelt-Struebe M, Kaever V, Resch K, J Cell Biochem 1989 40 397 406 10.1002/jcb.240400315 2777910 (Pubitemid 19186932)
86. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Meisel R, Zibert A, Laryea M, Gobel U, Daubener W, Dilloo D, Blood 2004 103 4619 4621 10.1182/blood-2003-11-3909 15001472 (Pubitemid 38745993)
87. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, Ferrara GB, The Journal of experimental medicine 2002 196 459 468 10.1084/jem.20020121 12186838
88. Effects of allogeneic bone marrow-derived mesenchymal stem cells on T and B lymphocytes from BXSB mice. Deng W, Han Q, Liao L, You S, Deng H, Zhao RC, DNA Cell Biol 2005 24 458 463 10.1089/dna.2005.24.458 16008514 (Pubitemid 40994557)
89. Human mesenchymal stem cells modulate B-cell functions. Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, Risso M, Gualandi F, Mancardi GL, Pistoia V, Uccelli A, Blood 2006 107 367 372 10.1182/blood-2005- 07-2657 16141348 (Pubitemid 43053565)
90. Mesenchymal stem cells stimulate antibody secretion in human B cells. Rasmusson I, Le Blanc K, Sundberg B, Ringden O, Scand J Immunol 2007 65 336 343 10.1111/j.1365-3083.2007.01905.x 17386024 (Pubitemid 46481102)
91. Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients. Traggiai E, Volpi S, Schena F, Gattorno M, Ferlito F, Moretta L, Martini A, Stem Cells 2008 26 562 569 10.1634/stemcells.2007-0528 18024418 (Pubitemid 351413617)
92. Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC. Hass R, Kasper C, Böhm S, Jacobs R, Cell Commun Signal 2011 9 12 10.1186/1478-811X-9-12 21569606
93. Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair. Huang XP, Sun Z, Miyagi Y, McDonald Kinkaid H, Zhang L, Weisel RD, Li RK, Circulation 2010 122 2419 2429 10.1161/CIRCULATIONAHA.110.955971 21098445
94. Mesenchymal stem cells and progenitor cells in connective tissue engineering and regenerative medicine: Is there a future for transplantation? Hilfiker A, Kasper C, Hass R, Haverich A, Langenbeck's Arch Surgery 2011 396 489 497 10.1007/s00423-011-0762-2
95. Mesenchymal stem cells and bone regeneration. Kraus KH, Kirker-Head C, Vet Surg 2006 35 232 242 10.1111/j.1532-950X.2006.00142.x 16635002
96. Mesenchymal stem cells in connective tissue engineering and regenerative medicine: applications in cartilage repair and osteoarthritis therapy. Mobasheri A, Csaki C, Clutterbuck AL, Rahmanzadeh M, Shakibaei M, Histol Histopathol 2009 24 347 366 19130405
97. Bone marrow stem cells and polymer hydrogels-two strategies for spinal cord injury repair. Sykova E, Jendelova P, Urdzikova L, Lesny P, Hejcl A, Cell Mol Neurobiol 2006 26 1113 1129 16633897 (Pubitemid 44924034)
98. Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy. Perin EC, Dohmann HF, Borojevic R, Silva SA, Sousa AL, Silva GV, Mesquita CT, Belem L, Vaughn WK, Rangel FO, Assad JA, Carvalho AC, Branco RV, Rossi MI, Dohmann HJ, Willerson JT, Circulation 2004 110 I213 II218 15364865
99. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Lazarus HM, Koc ON, Devine SM, Curtin P, Maziarz RT, Holland HK, Shpall EJ, McCarthy P, Atkinson K, Cooper BW, Gerson SL, Laughlin MJ, Loberiza FR, Moseley AB, Bacigalupo A, Biol Blood Marrow Transplant 2005 11 389 398 10.1016/j.bbmt.2005.02.001 15846293 (Pubitemid 40542932)
100. Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Horwitz EM, Prockop DJ, Gordon PL, Koo WW, Fitzpatrick LA, Neel MD, McCarville ME, Orchard PJ, Pyeritz RE, Brenner MK, Blood 2001 97 1227 1231 10.1182/blood.V97.5.1227 11222364 (Pubitemid 32183743)
101. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, Ringden O, Lancet 2004 363 1439 1441 10.1016/S0140-6736(04)16104-7 15121408 (Pubitemid 38586721)
102. Yun Z Impact of the hypoxic tumor microenvironment on the regulation of cancer stem cell characteristics. Lin Q, Cancer Biol Ther 2010 9 949 56 10.4161/cbt.9.12.12347 20581454
103. miR-335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cells. Tomé M, Lápez-Romero P, Albo C, Sepúlveda JC, Fernández-Gutiérrez B, Dopazo A, Bernad A, González MA, Cell Death Differ 2011 18 985 995 10.1038/cdd.2010.167 21164520
104. Endogenous human microRNAs that suppress breast cancer metastasis. Tavazoie SF, Alarcán C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL, Massagué J, Nature 2008 451 147 152 10.1038/nature06487 18185580
105. Mesenchymal stem cells in the colorectal tumor microenvironment: recent progress and implications. Hogan NM, Dwyer RM, Joyce MR, Kerin MJ, Int J Cancer 2012 131 1 7 10.1002/ijc.27458 22290082
106. Polarity proteins in migration and invasion. Etienne-Manneville S, Oncogene 2008 27 6970 6980 10.1038/onc.2008.347 19029938
107. Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo. Zhu W, Huang L, Li Y, Zhang X, Gu J, Yan Y, Xu X, Wang M, Qian H, Xu W, Cancer Lett 2012 315 28 37 10.1016/j.canlet.2011.10.002 22055459
108. microRNAs, Gap Junctional Intercellular Communication and Mesenchymal Stem Cells in Breast Cancer Metastasis. Gregory LA, Ricart RA, Patel SA, Lim PK, Lim P, Curr Cancer Ther Rev 2011 7 176 183 10.2174/157339411796234915 21886602
109. A potential role for gap junctions in breast cancer metastasis to bone. Donahue HJ, Saunders MM, Li Z, Mastro AM, Gay CV, Welch DR, J Musculoskelet Neuronal Interact 2003 3 156 161 15758356 (Pubitemid 36926850)
110. Potential novel targets in breast cancer. Rameshwar P, Curr Pharm Biotechnol 2009 10 148 153 10.2174/138920109787315024 19199946
111. Mesenchymal stem cells contribute to tumor cell proliferation by direct cell-cell contact interactions. Roorda BD, Elst A, Boer TG, Kamps WA, de Bont ES, Cancer Invest 2010 28 526 34 10.3109/07357900903179625 20210526
112. MUC1 initiates Src-CrkL-Rac1/Cdc42-mediated actin cytoskeletal protrusive motility after ligating intercellular adhesion molecule-1. Shen Q, Rahn JJ, Zhang J, Gunasekera N, Sun X, Shaw AR, Hendzel MJ, Hoffman P, Bernier A, Hugh JC, Mol Cancer Res 2008 6 555 567 10.1158/1541-7786.MCR-07-2033 18403635 (Pubitemid 351521837)
113. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Kufe D, Inghirami G, Abe M, Hayes D, Justi-Wheeler H, Schlom J, Hybridoma 1984 3 223 232 10.1089/hyb.1984.3.223 6094338 (Pubitemid 15184701)
114. The importance of MUC1 cellular localization in patients with breast carcinoma: an immunohistologic study of 71 patients and review of the literature. Rahn JJ, Dabbagh L, Pasdar M, Hugh JC, Cancer 2001 91 1973 1982 10.1002/1097-0142(20010601)91:11<1973::AID-CNCR1222>3.0.CO;2-A 11391575 (Pubitemid 32476360)
115. Differential mechanical response of mesenchymal stem cells and fibroblasts to tumor-secreted soluble factors. McGrail DJ, Ghosh D, Quach ND, Dawson MR, PLoS One 2012 7 33248 10.1371/journal.pone.0033248 22438903
116. Human umbilical cord Wharton's jelly stem cell (hWJSC) extracts inhibit cancer cell growth in vitro. Gauthaman K, Yee FC, Cheyyatraivendran S, Biswas A, Choolani M, Bongso A, J Cell Biochem 2012 113 2027 2039 10.1002/jcb.24073 22275115
117. Mesenchymal Stem Cells Overexpressing IFN- Inhibit Breast Cancer Growth and Metastases through Stat3 Signaling in a Syngeneic Tumor Model. Ling X, Marini F, Konopleva M, Schober W, Shi Y, Burks J, Clise-Dwyer K, Wang RY, Zhang W, Yuan X, Lu H, Caldwell L, Andreeff M, Cancer Microenviron 2010 3 83 95 10.1007/s12307-010-0041-8 21209776
118. Human umbilical cord blood mesenchymal stem cell-derived extracellular matrix prohibits metastatic cancer cell MDA-MB-231 proliferation. Sun B, Yu KR, Bhandari DR, Jung JW, Kang SK, Kang KS, Cancer Lett 2010 296 178 185 10.1016/j.canlet.2010.04.007 20435406
119. Overexpression of CXC chemokine receptors is required for the superior glioma-tracking property of umbilical cord blood-derived mesenchymal stem cells. Kim DS, Kim JH, Lee JK, Choi SJ, Kim JS, Jeun SS, Oh W, Yang YS, Chang JW, Stem Cells Dev 2009 18 511 519 10.1089/scd.2008.0050 18624673
120. Vascular endothelial growth factor A contributes to glioma-induced migration of human marrow stromal cells (hMSC). Schichor C, Birnbaum T, Etminan N, Schnell O, Grau S, Miebach S, Aboody K, Padovan C, Straube A, Tonn JC, Goldbrunner R, Exp Neurol 2006 199 301 310 10.1016/j.expneurol.2005.11.027 16574102 (Pubitemid 44202456)
121. Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines. Birnbaum T, Roider J, Schankin CJ, Padovan CS, Schichor C, Goldbrunner R, Straube A, J Neurooncol 2007 83 241 247 10.1007/s11060-007- 9332-4 17570034 (Pubitemid 46952234)
122. MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines. Ries C, Egea V, Karow M, Kolb H, Jochum M, Neth P, Blood 2007 109 4055 4063 10.1182/blood-2006-10-051060 17197427 (Pubitemid 46641761)
123. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Nakamura K, Ito Y, Kawano Y, Kurozumi K, Kobune M, Tsuda H, Bizen A, Honmou O, Niitsu Y, Hamada H, Gene Ther 2004 11 1155 1164 10.1038/sj.gt.3302276 15141157 (Pubitemid 39117311)
124. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Nakamizo A, Marini F, Amano T, Khan A, Studeny M, Gumin J, Chen J, Hentschel S, Vecil G, Dembinski J, Andreeff M, Lang FF, Cancer Res 2005 65 3307 3318 15833864 (Pubitemid 40524615)
125. Mesenchymal stem cells display tumor-specific tropism in an RCAS/Ntv-a glioma model. Doucette T, Rao G, Yang Y, Gumin J, Shinojima N, Bekele BN, Qiao W, Zhang W, Lang FF, Neoplasia 2011 13 716 725 21847363
126. Proteolytic Potential of the MSC Exosome Proteome: Implications for an Exosome-Mediated Delivery of Therapeutic Proteasome. Lai RC, Tan SS, Teh BJ, Sze SK, Arslan F, de Kleijn DP, Choo A, Lim SK, Int J Proteomics 2012 2012 971907 22852084
127. Mesenchymal stem cell: An efficient mass producer of exosomes for drug delivery. Yeo RW, Lai RC, Zhang B, Tan SS, Yin Y, Teh BJ, Lim SK, Adv Drug Deliv Rev 2012 Epub ahead of print
128. Multiple myeloma mesenchymal stem cells: characterization, origin, and tumor-promoting effects. Reagan MR, Ghobrial IM, Clin Cancer Res 2012 18 342 349 10.1158/1078-0432.CCR-11-2212 22065077
129. Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro. Guiducci S, Manetti M, Romano E, Mazzanti B, Ceccarelli C, Dal Pozzo S, Milia AF, Bellando-Randone S, Fiori G, Conforti ML, Saccardi R, Ibba-Manneschi L, Matucci-Cerinic M, Ann Rheum Dis 2011 70 2011 1221 10.1136/ard.2011.150607 21821866
130. Derivation of sarcomas from mesenchymal stem cells via inactivation of
131. Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Røsland GV, Svendsen A, Torsvik A, Sobala E, McCormack E, Immervoll H, Mysliwietz J, Tonn JC, Goldbrunner R, Lønning PE, Bjerkvig R, Schichor C, Cancer Res 2009 69 5331 5339 10.1158/0008-5472.CAN-08-4630 19509230
132. Role of mesenchymal stem cells in neurogenesis and nervous system repair. Maltman DJ, Hardy SA, Przyborski SA, Neurochem Int 2011 59 347 356 21718735
133. Bi-directional exchange of membrane components occurs during co-culture of mesenchymal stem cells and nucleus pulposus cells. Strassburg S, Hodson NW, Hill PI, Richardson SM, Hoyland JA, PLoS One 2012 7 3 33739 10.1371/journal. pone.0033739 22438989
134. Human mesenchymal stem cells respond to native but not oxidized damage associated molecular pattern molecules from necrotic (tumor) material. Lotfi R, Eisenbacher J, Solgi G, Fuchs K, Yildiz T, Nienhaus C, Rojewski MT, Schrezenmeier H, Eur J Immunol 2011 41 2021 2028 10.1002/eji.201041324 21538978
135. Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Mishra PJ, Mishra PJ, Humeniuk R, Medina DJ, Alexe G, Mesirov JP, Ganesan S, Glod JW, Banerjee D, Cancer Res 2008 68 4331 4339 10.1158/0008-5472.CAN-08-0943 18519693
136. Modeling sarcomagenesis using multipotent mesenchymal stem cells. Rodriguez R, Rubio R, Menendez P, Cell Res 2012 22 62 77 10.1038/cr.2011.157 21931359
137. Multipotent mesenchymal stromal cells: clinical applications and cancer modeling. Rodríguez R, García-Castro J, Trigueros C, García Arranz M, Menéndez P, Adv Exp Med Biol 2012 741 187 205 10.1007/978-1-4614-2098-9-13 22457111
138. Mesenchymal stem cells from primary breast cancer tissue promote cancer proliferation and enhance mammosphere formation partially via EGF/EGFR/Akt pathway. Yan XL, Fu CJ, Chen L, Qin JH, Zeng Q, Yuan HF, Nan X, Chen HX, Zhou JN, Lin YL, Zhang XM, Yu CZ, Yue W, Pei XT, Breast Cancer Res Treat 2012 132 153 64 10.1007/s10549-011-1577-0 21584665
139. Epithelial-Mesenchymal Transition-Derived Cells Exhibit Multi-Lineage Differentiation Potential Similar to Mesenchymal Stem Cells. Battula VL, Evans KW, Hollier BG, Shi Y, Marini FC, Ayyanan A, Wang RY, Brisken C, Guerra R, Andreeff M, Mani SA, Stem Cells 2010 28 1435 1445 10.1002/stem.467 20572012
140. Characterization of human breast cancer epithelial cells (HBCEC) derived from long term cultured biopsies. Hass R, Bertram C, J Exp & Clin Cancer Res 2009 28 127 10.1186/1756-9966-28-127 22952145
141. Mesenchymal stem cells expressing GD2 and CD271 correlate with breast cancer-initiating cells in bone marrow. De Giorgi U, Cohen EN, Gao H, Mego M, Lee BN, Lodhi A, Cristofanilli M, Lucci A, Reuben JM, Cancer Biol Ther 2011 11 812 815 10.4161/cbt.11.9.15178 21358274
142. Breast cancer stem cells, cytokine networks, and the tumor microenvironment. Korkaya H, Liu S, Wicha MS, J Clin Invest 2011 121 3804 3809 10.1172/JCI57099 21965337
143. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA, Nature 2007 449 557 563 10.1038/nature06188 17914389 (Pubitemid 47525152)
144. Human decidual stromal cells secrete C-X-C motif chemokine 13, express B cell-activating factor and rescue B lymphocytes from apoptosis: distinctive characteristics of follicular dendritic cells. Mũoz-Fernández R, Prados A, Leno-Durán E, Blázquez A, García-Fernández JR, Ortiz-Ferrán G, Olivares EG, Hum Reprod 2012 27 2775 2784 10.1093/humrep/des198 22718279